Neuroprotective Effects of Early Rehabilitation Following Acute Ischemic Stroke

Abstract

Whether the timing of rehabilitation after acute ischemic stroke shapes the brain's own capacity for recovery, not merely the pace of functional retraining, has become a central question in stroke rehabilitation research over the past decade. This article synthesizes the clinical trial literature built around the AVERT (A Very Early Rehabilitation Trial) program alongside decades of rodent focal-ischemia research on enriched, task-specific rehabilitative training delivered at varying delays after stroke. The AVERT phase III trial's counter-intuitive finding, that a very early, high-dose mobilisation protocol reduced the odds of a favourable three-month outcome relative to usual-care timing, is reconciled through the trial's own prespecified dose-response analysis, which found earlier onset and higher session frequency independently favourable while implicating long individual session duration in the unfavourable primary result. This clinical pattern maps closely onto rodent studies showing that rehabilitative training begun too early after focal ischemia fails to produce the functional and dendritic benefit seen with training begun after a short delay, and that this benefit fades again if training is delayed too far into the sub-acute period. We situate both literatures within the organizational scaffolding of stroke unit care and early supported discharge, and within the modality-specific evidence base for constraint-induced movement therapy, task-specific training, fitness training, and robotic-assisted gait training. We conclude that the evidence supports an early-but-not-immediate, frequent-but-not-overly-prolonged pattern of rehabilitative activity as neuroprotective and neurorestorative, while identifying the absence of an adequately powered confirmatory human dose-response trial and a direct human biomarker bridge to the rodent timing mechanism as the field's most pressing open questions.